Suppr超能文献

阿尔茨海默病患者基因中的杂合子和纯合子变异:临床、神经影像学和神经病理学发现。

Heterozygous and Homozygous Variants in Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.

机构信息

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Biochemistry and Molecular Genetic Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.

出版信息

Int J Mol Sci. 2022 Apr 11;23(8):4230. doi: 10.3390/ijms23084230.

Abstract

In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer’s disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or family history suggestive of autosomal dominant dementia. Data analysis was based on a custom panel that included 46 genes related to AD and dementia. SORL1 variants were present in a high proportion of patients with candidate variants (15%, 3/20). We expand the clinical manifestations associated with the SORL1 gene by reporting detailed clinical and neuroimaging findings of six unrelated patients with AD and SORL1 mutations. We also present for the first time a patient with the homozygous truncating variant c.364C>T (p.R122*) in SORL1, who also had severe cerebral amyloid angiopathy. Furthermore, we report neuropathological findings and immunochemistry assays from one patient with the splicing variant c.4519+5G>A in the SORL1 gene, in which AD was confirmed by neuropathological examination. Our results highlight the heterogeneity of clinical presentation and familial dementia background of SORL1-associated AD and suggest that SORL1 might be contributing to AD development as a risk factor gene rather than as a major autosomal dominant gene.

摘要

在过去的几年中,SORL1 基因强烈暗示与阿尔茨海默病(AD)的发展有关。我们对 37 名有早发性痴呆或家族史提示常染色体显性遗传性痴呆的患者进行了全外显子组测序。数据分析基于一个包含 46 个与 AD 和痴呆相关基因的定制面板。候选变异患者中存在高比例的 SORL1 变异(15%,3/20)。我们通过报告六位患有 AD 和 SORL1 突变的无关患者的详细临床和神经影像学发现,扩展了与 SORL1 基因相关的临床表现。我们还首次报告了一位 SORL1 基因中 c.364C>T(p.R122*)纯合截断变异的患者,该患者还伴有严重的脑淀粉样血管病。此外,我们报告了一位 SORL1 基因中 c.4519+5G>A 剪接变异患者的神经病理学发现和免疫化学检测,该患者的 AD 通过神经病理学检查得到证实。我们的结果强调了 SORL1 相关 AD 的临床表现和家族性痴呆背景的异质性,并表明 SORL1 可能作为一个风险因素基因而不是一个主要的常染色体显性基因参与 AD 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/9024679/93a0804a62bc/ijms-23-04230-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验